发短信有助于慢性疾病的药物粘附吗？

慢性疾病中的药物粘附性差。可以通过遵守电话短信帮助吗？在线发布的新文章贾马内科在Jay Thakkar，F.R.A.C.P.和Clara K. Chow，Ph.D.的乔治全球卫生学院，澳大利亚大学乔治研究所，普拉拉克，博士，审查了该问题。

荟萃分析包括16随机临床试验评估文本消息对慢性病药物依从性的影响。

结果表明文本消息与药物遵守的可能性增加有关。然而，作者在解释结果时，作者谨慎，部分原因是因为依赖于自我报告药物遵守。作者建议未来的研究专注于适当的患者群体，效果的寿命和对临床结果的影响。

In a related commentary, R. Brian Haynes, M.D., Ph.D., of McMaster University, Hamilton, Ontario, Canada, and coauthors write: "In summary, future adherence research needs to overcome the common methodological pitfalls that are still plaguing the field. As Thakkar et al show, TM [text messaging] has potential as a widespread, low-cost technology but will need more development and rigorous testing to determine if it has real, enduring and patient-important benefits that are worth the investment."

---

---